A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of tadalafil once daily in subjects with Erectile dysfunction (ED) who are naive to PDE5 inhibitors

Authors
Category Primary study
JournalJournal of Sexual Medicine
Year 2010
This article has no abstract
Epistemonikos ID: f61c093eb8068f5197ed3f495ac891db2ed7e316
First added on: Feb 04, 2025